News

Immunodominant epitopes identified for designing peptide-based vaccine against SARS-CoV-2

There are currently no licensed vaccines available for COVID-19. While several antiviral drugs have been tested, none has proved to be completely effective against the disease. In a study just published in the journal MDPI Vaccines, researchers from Bar-Ilan University have identified a set of potential immunodominant epitopes from the SARS-CoV-2 proteome. These epitopes are capable of generating both antibody- and cell-mediated immune responses. The findings of this work may thus contribute to developing a peptide vaccine against SARS-CoV-2 infections which can stop the COVID-19 outbreak and future pandemics caused by coronaviruses ... Read More

Mutation-proof: Israeli scientist nears vaccine that’ll cope with COVID changes

Bar Ilan researcher says she has laid the groundwork after researching coronavirus and identifying protein segments that could be replicated to build immunity ... Read More

Israeli researchers on road to new coronavirus passive vaccine

Seven of the epitopes are potentially effective vaccine candidates. The research shows that they could cover as much as 87% of the world population ... Read More

Israeli varsity says new findings may lead to Covid vaccine

Israeli researchers have identified coronavirus molecules that lead to the development of a vaccine against the virus, Bar Ilan University (BIU) in central Israel said ... Read More